Growing collaborations between academic institutions, biotechnology companies, and diagnostic laboratories are encouraging innovation in antibody development. Such partnerships facilitate knowledge sharing, biomarker validation, and the development of specialized research reagents. Collaborative research initiatives are also supporting a deeper understanding of EXT1-associated autoimmune...